Deliver Your News to the World

CybeRelease: (OTC: BDGR) Gets Featured Report From OTC Reporter


WEBWIRE

(CybeRelease, April 4, 2006) - Lake Harmony, PA - OTCReporter.com’s “Featured Company”, Black Dragon Resources (OTC PK: BDGR), has announced major revenue increase news this morning. The following is an edited version.

Black Dragon Resource Companies, Inc. (BDGR) announced that it expects its sales for the fourth quarter ended December 31, 2005, on an unedited basis to be approximately $709,000, up almost 26% over the previous quarter. Sales for the 2005 fiscal year end December 31 are expected to total approximately $1.655 million. The revenues for the year increased sequentially during the year; $421,000 for the first and second quarter combined; $525,000 for the third quarter and $709,000 for the fourth quarter. The Company expects revenues for the first quarter 2006 to approach $1 million, a record quarter for the Company and an increase of over 41% from the last quarter of 2005.

The Company expects an audit of its year-end numbers to be completed in the next ninety-days.

Mr. Rick Michael, President of Black Dragon stated, “Our recently released reserve report and report by Red Chip Companies have both confirmed our asset base and revenue potential. We are gratified by our results for 2005 and expect this momentum to continue into 2006. We believe that our revenue goal for 2006 of approximately $14 million is highly achievable.”

For a Free Newsletter and more information, go to www.OTCReporter.com.

CybeRelease Gainers are NaviSite, Inc. (Nasdaq: NAVI), Linktone Ltd. (Nasdaq: LTON), Valentis, Inc. (Nasdaq: VLTS), Avigen, Inc. (Nasdaq: AVGN), Ciphergen Biosystems, Inc. (Nasdaq: CIPH), Global ePoint, Inc. (Nasdaq: GEPT), GigaMedia Limited (Nasdaq: GIGM) and Catuity Inc. (Nasdaq: CTTY).

CybeRelease Decliners areTraffic.com, Inc. (Nasdaq: TRFC), Fiberstars, Inc. (Nasdaq: FBST), Quanta Capital Holdings Ltd. (Nasdaq: QNTA), Radware Ltd. (Nasdaq: RDWR), Rockwell Medical Technologies, Inc. (Nasdaq: RMTI), Indus International, Inc. (Nasdaq: IINT), Array BioPharma Inc. (Nasdaq: ARRY) and United Retail Group, Inc. (Nasdaq: URGI).

Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid CybeRelease $500.00 for the publication of this report. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation and do no trading of any kind.







WebWireID12095





This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.